Workflow
Abbott (ABT) Q3 Earnings Meet Estimates
AbbottAbbott(US:ABT) ZACKS·2025-10-15 13:41

Core Insights - Abbott reported quarterly earnings of $1.3 per share, matching the Zacks Consensus Estimate, and showing an increase from $1.21 per share a year ago [1] - The company posted revenues of $11.37 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.24%, but up from $10.64 billion year-over-year [2] - Abbott's shares have increased by approximately 17.8% year-to-date, outperforming the S&P 500's gain of 13% [3] Earnings Performance - Over the last four quarters, Abbott has surpassed consensus EPS estimates two times [2] - The current consensus EPS estimate for the upcoming quarter is $1.49, with expected revenues of $11.75 billion, and for the current fiscal year, the estimate is $5.15 on revenues of $44.66 billion [7] Market Outlook - The sustainability of Abbott's stock price movement will largely depend on management's commentary during the earnings call [3] - The Zacks Rank for Abbott is currently 4 (Sell), indicating expectations of underperformance in the near future [6] - The Medical - Products industry, to which Abbott belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]